MS on DRL (healthcare conf takeaways)
Over Weight, TP Rs 5099
gRevlimid launch should help stem erosion in US
F24 should benefit from a strong ruble
After sequential fall in 1Q US biz, co now expects to grow this biz over next several qtrs
India biz should grow 100-200bps ahead of market
